Swibrace enters the clinical phase

Founded in 2017, Swibrace, in collaboration with the Idiap Research Institute and HES-SO University of Applied Sciences in Fribourg, is pioneering the development of orthopedic splints for treating distal radius and scaphoid fractures—complex and rare injuries typically resulting from high-energy traumas like falls from a height or motorcycle accidents. By harnessing advanced 3D printing and additive manufacturing techniques, the Swibrace team has crafted patient-specific, patented orthopedic splints adapted to each individual’s anatomy.

Unlike traditional splints and off-the-shelf splints, Swibrace’s Patient Support and Brace Systems (PSABs) are breathable and waterproof, significantly reducing the risk of infections and mitigating muscle atrophy. This innovative approach fosters a more comfortable and efficient healing process for patients.

Earlier this year, the Freiburg-based startup embarked on a collaborative project with Inselspital to manufacture 3D-printed wrist splints. These splints were rigorously validated in a clinical study that was published in the Journal of Wrist Surgery. Professor Frédéric Schuind, the CEO and founder of Swibrace SA, expressed enthusiasm stating, “We are pleased to introduce our 3D-printed wrist splints—a demonstration of Swibrace’s commitment to patient-specific care. The study highlights how additive manufacturing can improve the treatment of distal radius, rhizarthrosis, and scaphoid fractures.”

This milestone also marks the startup’s entry into the clinical and commercialisation phase, allowing patients to request wrist braces at Inselspital, or order them via their website. With further studies underway, the company is dedicated to making its braces accessible and is actively engaged in dialogue with several partners to expand its reach. In addition to splints for wrist fractures, Swibrace plans to expand its portfolio to include sprints for scaphoid fractures, as well as other long-term arm splints.

(Press release/RAN)